Clover Health Investments, Corp. (NASDAQ:CLOV) Short Interest Update

Clover Health Investments, Corp. (NASDAQ:CLOV - Get Free Report) was the target of a large growth in short interest during the month of December. As of December 31st, there was short interest totalling 15,960,000 shares, a growth of 9.0% from the December 15th total of 14,640,000 shares. Based on an average trading volume of 6,180,000 shares, the days-to-cover ratio is presently 2.6 days.

Institutional Investors Weigh In On Clover Health Investments

A number of large investors have recently bought and sold shares of CLOV. Geode Capital Management LLC lifted its holdings in shares of Clover Health Investments by 21.9% during the 3rd quarter. Geode Capital Management LLC now owns 4,828,701 shares of the company's stock worth $13,622,000 after acquiring an additional 868,501 shares during the period. Charles Schwab Investment Management Inc. grew its position in Clover Health Investments by 5.3% in the third quarter. Charles Schwab Investment Management Inc. now owns 3,000,505 shares of the company's stock valued at $8,461,000 after acquiring an additional 150,550 shares during the last quarter. State Street Corp grew its position in Clover Health Investments by 65.0% in the third quarter. State Street Corp now owns 2,189,380 shares of the company's stock valued at $6,174,000 after acquiring an additional 862,621 shares during the last quarter. Connor Clark & Lunn Investment Management Ltd. grew its position in Clover Health Investments by 75.7% in the third quarter. Connor Clark & Lunn Investment Management Ltd. now owns 1,128,171 shares of the company's stock valued at $3,181,000 after acquiring an additional 485,987 shares during the last quarter. Finally, XTX Topco Ltd acquired a new position in Clover Health Investments during the second quarter worth about $932,000. 19.77% of the stock is currently owned by institutional investors and hedge funds.

Clover Health Investments Trading Up 0.2 %

CLOV stock traded up $0.01 during trading hours on Friday, hitting $4.08. 5,428,788 shares of the stock were exchanged, compared to its average volume of 4,336,139. The company has a 50-day simple moving average of $3.36 and a two-hundred day simple moving average of $3.01. The firm has a market capitalization of $2.04 billion, a P/E ratio of -20.40 and a beta of 1.95. Clover Health Investments has a 12 month low of $0.61 and a 12 month high of $4.71.

Clover Health Investments (NASDAQ:CLOV - Get Free Report) last announced its earnings results on Wednesday, November 6th. The company reported ($0.02) EPS for the quarter, topping the consensus estimate of ($0.03) by $0.01. The company had revenue of $330.99 million for the quarter, compared to analysts' expectations of $347.60 million. Clover Health Investments had a negative net margin of 5.92% and a negative return on equity of 25.46%. During the same period last year, the firm earned ($0.09) earnings per share. On average, equities research analysts predict that Clover Health Investments will post -0.12 earnings per share for the current year.

Analyst Ratings Changes

CLOV has been the topic of several research analyst reports. UBS Group started coverage on Clover Health Investments in a research note on Monday, October 7th. They set a "neutral" rating and a $4.00 price objective on the stock. Craig Hallum assumed coverage on Clover Health Investments in a research note on Tuesday, December 17th. They issued a "buy" rating and a $6.00 price target for the company.

About Clover Health Investments

Clover Health Investments, Corp. provides medicare advantage plans in the United States. It operates through two segments: Insurance and Non-Insurance. It also offers Clover Assistant, a cloud-based software platform, that enables physicians to detect, identify, and manage chronic diseases earlier; and access to data-driven and personalized insights for the patients they treat.